Natco Pharma shares surged after CDSCO approved semaglutide injection for India. USFDA issued seven observations for Chennai API unit. Strong earnings boosted revenue and net profit year-on-year.
Natco Pharma shares surged after CDSCO approved semaglutide injection for India. USFDA issued seven observations for Chennai API unit. Strong earnings boosted revenue and net profit year-on-year.